SCHEMBL2947337

SCHEMBL2947337

O=C(O)c1ccccc1NC(=O)C1CC1c1ccc(OC(F)F)c(OC(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTB4R Q15722 1/20 0.48
▸ TAS2R14 Q9NYV8 1/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ TEAD4 Q15561 1/20 0.45
▸ DEGS1 O15121 1/20 0.41
▸ PLA2G1B P04054 1/20 0.41
▸ ATG4B Q9Y4P1 1/20 0.41
▸ HCAR2 Q8TDS4 1/20 0.41
▸ RBP4 P02753 1/20 0.39
▸ PDE4A P27815 2/20 0.39
▸ PDE4B Q07343 2/20 0.39
▸ PDE4C Q08493 2/20 0.39
▸ PDE4D Q08499 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CHEK1 O14757 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ MAPK8 P45983 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19695910 0.86 KDM4C (0.42) LTB4RALDH1A1PDE4APDE4BPDE4C
SCHEMBL2950480 0.84 LTB4R (0.61) LTB4RMEN1ALDH1A1KMT2APDE4D
SCHEMBL9607119 0.83 LTB4R (0.48) LTB4RALDH1A1DEGS1HCAR2RBP4
SCHEMBL19695909 0.81 LTB4R (0.52) LTB4RMEN1ALDH1A1KMT2APDE4D
SCHEMBL19695907 0.81 LTB4R (0.52) LTB4RMEN1ALDH1A1KMT2APDE4D
SCHEMBL19695945 0.80 LTB4R (0.56) LTB4RMEN1ALDH1A1MAPTKMT2A
SCHEMBL19695908 0.79 LTB4R (0.36) LTB4RALDH1A1DEGS1HCAR2PDE4A
SCHEMBL6790187 0.78 HCAR2 (0.63) LTB4RMEN1KMT2ADEGS1HCAR2
SCHEMBL6790194 0.78 HCAR2 (0.63) LTB4RMEN1KMT2ADEGS1HCAR2
SCHEMBL6790198 0.78 HCAR2 (0.63) LTB4RMEN1KMT2ADEGS1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3485883-A1 METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION OccuRx Pty Ltd (AU) 2019-05-22 — — EP disclosed
US-9839640-B2 Methods of treating eye diseases associated with inflammation and vascular proliferation OCCURX PTY LTD (AU) 2017-12-12 — — US disclosed
WO-2010144959-A1 ANALOGUES OF ANTI-FIBROTIC AGENTS FIBROTECH THERAPEUTICS PTY LTD (AU) 2010-12-23 — — WO disclosed
Send feedback